Inventor
GARDNER DANIEL S
US37 patents
⚠️ This page may combine multiple inventors who share the name “GARDNER DANIEL S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
25 patentsUS7183270B2Feb 27, 2007
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO52 citations96
US7163937B2Jan 16, 2007
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO29 citations92
US7601844B2Oct 13, 2009
Piperidinyl derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO19 citations91
US10294229B2May 21, 2019
Heteroaryl substituted aminopyridine compounds
BRISTOL MYERS SQUIBB CO9 citations84
US7378409B2May 27, 2008
Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO20 citations83
US7338947B2Mar 4, 2008
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO6 citations74
US6586446B1Jul 1, 2003
Bicyclic and tricyclic amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO8 citations74
US7482335B2Jan 27, 2009
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO6 citations73
US10202390B2Feb 12, 2019
Heteroaryl substituted aminopyridine compounds
BRISTOL MYERS SQUIBB CO3 citations71
US9657009B2May 23, 2017
Heteroaryl substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO4 citations71
US9546153B2Jan 17, 2017
Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO5 citations71
US9169252B2Oct 27, 2015
Heteroaryl substituted nicotinamide compounds
BRISTOL MYERS SQUIBB CO5 citations71
US7985861B2Jul 26, 2011
Piperidinyl derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO3 citations61
US10479793B2Nov 19, 2019
Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
BRISTOL MYERS SQUIBB CO1 citations59
US11981680B2May 14, 2024
Substituted thienopyrroles as PAD4 inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US10544133B2Jan 28, 2020
Heteroaryl substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO0 citations52
US9221819B2Dec 29, 2015
Spirocyclic compounds as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations52
US7829571B2Nov 9, 2010
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations52
US7550500B2Jun 23, 2009
Bicyclic and tricyclic amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations52
US7291744B2Nov 6, 2007
N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO2 citations52
US6992091B2Jan 31, 2006
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations52
US10023562B2Jul 17, 2018
Heteroaryl substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO0 citations51
US12492202B2Dec 9, 2025
Macrocyclic PAD4 inhibitors useful as immunosuppressant
BRISTOL MYERS SQUIBB CO0 citations46
US12473304B2Nov 18, 2025
Heterocyclic PAD4 inhibitors
BRISTOL MYERS SQUIBB CO0 citations43
US10618903B2Apr 14, 2020
Heteroaryl substituted aminopyridine compounds
BRISTOL MYERS SQUIBB CO0 citations39
BRISTOL MYERS SQUIBB PHARMA CO
5 patentsUS6521592B2Feb 18, 2003
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO28 citations92
US6864380B2Mar 8, 2005
Benzylcycloalkyl amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO5 citations74
US7126010B2Oct 24, 2006
Benzylcycloalkyl amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO2 citations63
US6960666B2Nov 1, 2005
Bicyclic and tricyclic amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO2 citations63
US6784200B2Aug 31, 2004
Bicyclic and tricyclic amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO4 citations63